KEY PRODUCTS
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 3STRIDES PHARMA INTL
01 310792262
01 3Blank
01 3Y
01 32039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
